메뉴 건너뛰기




Volumn 9, Issue 6, 2013, Pages 346-356

The GH/IGF-1 axis in obesity: Pathophysiology and therapeutic considerations

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; LEPTIN; LIPID; MESSENGER RNA; PIOGLITAZONE; PLACEBO; SOMATOMEDIN C;

EID: 84879117813     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2013.64     Document Type: Review
Times cited : (179)

References (146)
  • 1
    • 65249171425 scopus 로고    scopus 로고
    • Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects
    • Møller, N. & Jørgensen, J. O. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30, 152-177 (2009).
    • (2009) Endocr. Rev. , vol.30 , pp. 152-177
    • Møller, N.1    Jørgensen, J.O.2
  • 2
    • 0002751873 scopus 로고
    • Effects of human growth hormone on muscle and adipose tissue metabolism in the forearm of man
    • Rabinowitz, D., Klassen, G. A. & Zierler, K. L. Effects of human growth hormone on muscle and adipose tissue metabolism in the forearm of man. J. Clin. Invest. 44, 51-61 (1965).
    • (1965) J. Clin. Invest. , vol.44 , pp. 51-61
    • Rabinowitz, D.1    Klassen, G.A.2    Zierler, K.L.3
  • 3
    • 0014440037 scopus 로고
    • Calorigenic effect of human growth hormone in obesity
    • Bray, G. A. Calorigenic effect of human growth hormone in obesity. J. Clin. Endocrinol. Metab. 29, 119-122 (1969).
    • (1969) J. Clin. Endocrinol. Metab. , vol.29 , pp. 119-122
    • Bray, G.A.1
  • 4
    • 0027514167 scopus 로고
    • Treatment of adults with growth hormone (GH) deficiency with recombinant human GH
    • Bengtsson, B. A. et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J. Clin. Endocrinol. Metab. 76, 309-317 (1993).
    • (1993) J. Clin. Endocrinol. Metab. , vol.76 , pp. 309-317
    • Bengtsson, B.A.1
  • 5
    • 0028264279 scopus 로고
    • Growth hormone and hepatic lipoprotein metabolism
    • Angelin, B. & Rudling, M. Growth hormone and hepatic lipoprotein metabolism. Curr. Opin. Lipidol. 5, 160-165 (1994).
    • (1994) Curr. Opin. Lipidol. , vol.5 , pp. 160-165
    • Angelin, B.1    Rudling, M.2
  • 7
    • 0030454148 scopus 로고    scopus 로고
    • Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency
    • Böger, R. H. et al. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. J. Clin. Invest. 98, 2706-2713 (1996).
    • (1996) J. Clin. Invest. , vol.98 , pp. 2706-2713
    • Böger, R.H.1
  • 8
    • 0031792510 scopus 로고    scopus 로고
    • Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency
    • [No authors listed]
    • [No authors listed] Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J. Clin. Endocrinol. Metab. 83, 379-381 (1998).
    • (1998) J. Clin. Endocrinol. Metab , vol.83 , pp. 379-381
  • 9
    • 33847249410 scopus 로고    scopus 로고
    • Management of adult growth hormone deficiency
    • Johannsson, G. Management of adult growth hormone deficiency. Endocrinol. Metab. Clin. North Am. 36, 203-220 (2007).
    • (2007) Endocrinol. Metab. Clin. North Am. , vol.36 , pp. 203-220
    • Johannsson, G.1
  • 10
    • 2442526224 scopus 로고    scopus 로고
    • Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: A meta-analysis of blinded, randomized, placebo-controlled trials
    • Maison, P. et al. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a meta-analysis of blinded, randomized, placebo-controlled trials. J. Clin. Endocrinol. Metab. 89, 2192-2199 (2004).
    • (2004) J. Clin. Endocrinol. Metab. , vol.89 , pp. 2192-2199
    • Maison, P.1
  • 11
    • 0034887335 scopus 로고    scopus 로고
    • Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors
    • Clasey, J. L. et al. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors. J. Clin. Endocrinol. Metab. 86, 3845-3852 (2001).
    • (2001) J. Clin. Endocrinol. Metab. , vol.86 , pp. 3845-3852
    • Clasey, J.L.1
  • 12
    • 0030737928 scopus 로고    scopus 로고
    • Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults
    • Vahl, N. et al. Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults. Am. J. Physiol. 272, E1108-E1116 (1997).
    • (1997) Am. J. Physiol. , vol.272
    • Vahl, N.1
  • 13
    • 0030663542 scopus 로고    scopus 로고
    • Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: Relation to age, sex, and body composition
    • Vahl, N., Møller, N., Lauritzen, T., Christiansen, J. S. & Jørgensen, J. O. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition. J. Clin. Endocrinol. Metab. 82, 3612-3618 (1997).
    • (1997) J. Clin. Endocrinol. Metab. , vol.82 , pp. 3612-3618
    • Vahl, N.1    Møller, N.2    Lauritzen, T.3    Christiansen, J.S.4    Jørgensen, J.O.5
  • 14
    • 77953171777 scopus 로고    scopus 로고
    • A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation
    • Lu, C., Kumar, P. A., Fan, Y., Sperling, M. A. & Menon, R. K. A novel effect of growth hormone on macrophage modulates macrophage-dependent adipocyte differentiation. Endocrinology 151, 2189-2199 (2010).
    • (2010) Endocrinology , vol.151 , pp. 2189-2199
    • Lu, C.1    Kumar, P.A.2    Fan, Y.3    Sperling, M.A.4    Menon, R.K.5
  • 15
    • 33747079946 scopus 로고    scopus 로고
    • Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor i
    • Fleenor, D., Arumugam, R. & Freemark, M. Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm. Res. 66, 101-110 (2006).
    • (2006) Horm. Res. , vol.66 , pp. 101-110
    • Fleenor, D.1    Arumugam, R.2    Freemark, M.3
  • 16
    • 34547179806 scopus 로고    scopus 로고
    • Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells
    • Lyuh, E. et al. Dose-specific or dose-dependent effect of growth hormone treatment on the proliferation and differentiation of cultured neuronal cells. Growth Horm. IGF Res. 17, 315-322 (2007).
    • (2007) Growth Horm. IGF Res. , vol.17 , pp. 315-322
    • Lyuh, E.1
  • 17
    • 67349116804 scopus 로고    scopus 로고
    • Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system
    • Hattori, N. Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Horm. IGF Res. 19, 187-197 (2009).
    • (2009) Growth Horm. IGF Res. , vol.19 , pp. 187-197
    • Hattori, N.1
  • 18
    • 3242738413 scopus 로고    scopus 로고
    • Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: Relationship to GH-binding protein
    • Fisker, S. et al. Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein. Eur. J. Endocrinol. 150, 773-777 (2004).
    • (2004) Eur. J. Endocrinol. , vol.150 , pp. 773-777
    • Fisker, S.1
  • 19
    • 0035092767 scopus 로고    scopus 로고
    • Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: Impact of GH treatment
    • Fisker, S. et al. Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment. J. Clin. Endocrinol. Metab. 86, 792-796 (2001).
    • (2001) J. Clin. Endocrinol. Metab. , vol.86 , pp. 792-796
    • Fisker, S.1
  • 20
    • 0028154380 scopus 로고
    • Growth hormone treatment of obese women for 5 wk: Effect on body composition and adipose tissue LPL activity
    • Richelsen, B. et al. Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity. Am. J. Physiol. 266, E211-E216 (1994).
    • (1994) Am. J. Physiol. , vol.266
    • Richelsen, B.1
  • 21
    • 0034289895 scopus 로고    scopus 로고
    • The mechanism of effect of growth hormone on preadipocyte and adipocyte function
    • Nam, S. Y. & Lobie, P. E. The mechanism of effect of growth hormone on preadipocyte and adipocyte function. Obes Rev. 1, 73-86 (2000).
    • (2000) Obes Rev. , vol.1 , pp. 73-86
    • Nam, S.Y.1    Lobie, P.E.2
  • 22
    • 84861970804 scopus 로고    scopus 로고
    • The insulin-like growth factors in adipogenesis and obesity
    • v-vi
    • Garten, A., Schuster, S. & Kiess, W. The insulin-like growth factors in adipogenesis and obesity. Endocrinol. Metab. Clin. North Am. 41, 283-295, v-vi (2012).
    • (2012) Endocrinol. Metab. Clin. North Am. , vol.41 , pp. 283-295
    • Garten, A.1    Schuster, S.2    Kiess, W.3
  • 23
    • 77949525237 scopus 로고    scopus 로고
    • Aging, depot origin, and preadipocyte gene expression
    • Cartwright, M. J. et al. Aging, depot origin, and preadipocyte gene expression. J. Gerontol. A. Biol. Sci. Med. Sci. 65, 242-251 (2010).
    • (2010) J. Gerontol. A. Biol. Sci. Med. Sci. , vol.65 , pp. 242-251
    • Cartwright, M.J.1
  • 24
    • 33846032618 scopus 로고    scopus 로고
    • Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns
    • Tchkonia, T. et al. Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am. J. Physiol. Endocrinol. Metab. 292, E298-E307 (2007).
    • (2007) Am. J. Physiol. Endocrinol. Metab. , vol.292
    • Tchkonia, T.1
  • 25
    • 84870273698 scopus 로고    scopus 로고
    • Clinical relevance of adipokines
    • Blüher, M. Clinical relevance of adipokines. Diabetes Metab. J. 36, 317-327 (2012).
    • (2012) Diabetes Metab. J. , vol.36 , pp. 317-327
    • Blüher, M.1
  • 26
    • 78650835266 scopus 로고    scopus 로고
    • The somatotrope as a metabolic sensor: Deletion of leptin receptors causes obesity
    • Childs, G. V. et al. The somatotrope as a metabolic sensor: deletion of leptin receptors causes obesity. Endocrinology 152, 69-81 (2011).
    • (2011) Endocrinology , vol.152 , pp. 69-81
    • Childs, G.V.1
  • 27
    • 84869233588 scopus 로고    scopus 로고
    • Human BAT possesses molecular signatures that resemble beige/brite cells
    • Sharp, L. Z. et al. Human BAT possesses molecular signatures that resemble beige/brite cells. PLoS ONE 7, e49452 (2012).
    • (2012) PLoS ONE , vol.7
    • Sharp, L.Z.1
  • 28
    • 81155138295 scopus 로고    scopus 로고
    • Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues
    • Lin, L. et al. Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 10, 996-1010 (2011).
    • (2011) Aging Cell , vol.10 , pp. 996-1010
    • Lin, L.1
  • 29
    • 79955044996 scopus 로고    scopus 로고
    • Architecture and the extracellular matrix: The still unappreciated components of the adipose tissue
    • Divoux, A. & Clément, K. Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue. Obes. Rev. 12, e494-e503 (2011).
    • (2011) Obes. Rev. , vol.12
    • Divoux, A.1    Clément, K.2
  • 30
    • 0035168994 scopus 로고    scopus 로고
    • Gene expression in visceral and subcutaneous adipose tissues
    • Vidal, H. Gene expression in visceral and subcutaneous adipose tissues. Ann. Med. 33, 547-555 (2001).
    • (2001) Ann. Med. , vol.33 , pp. 547-555
    • Vidal, H.1
  • 31
    • 84872144478 scopus 로고    scopus 로고
    • Adipose tissue heterogeneity: Implication of depot differences in adipose tissue for obesity complications
    • Lee, M. J., Wu, Y. & Fried, S. K. Adipose tissue heterogeneity: Implication of depot differences in adipose tissue for obesity complications. Mol. Aspects Med. 34, 1-11 (2013).
    • (2013) Mol. Aspects Med. , vol.34 , pp. 1-11
    • Lee, M.J.1    Wu, Y.2    Fried, S.K.3
  • 32
    • 79957916782 scopus 로고    scopus 로고
    • Adipose tissue remodeling and obesity
    • Sun, K., Kusminski, C. M. & Scherer, P. E. Adipose tissue remodeling and obesity. J. Clin. Invest. 121, 2094-2101 (2011).
    • (2011) J. Clin. Invest. , vol.121 , pp. 2094-2101
    • Sun, K.1    Kusminski, C.M.2    Scherer, P.E.3
  • 33
    • 79958153897 scopus 로고    scopus 로고
    • Growth hormone and adipose tissue: Beyond the adipocyte
    • Berryman, D. E. et al. Growth hormone and adipose tissue: beyond the adipocyte. Growth Horm. IGF Res. 21, 113-123 (2011).
    • (2011) Growth Horm. IGF Res. , vol.21 , pp. 113-123
    • Berryman, D.E.1
  • 34
    • 84856467002 scopus 로고    scopus 로고
    • Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women
    • Erman, A., Veilleux, A., Tchernof, A. & Goodyer, C. G. Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women. Int. J. Obes. (Lond.) 35, 1511-1519 (2011).
    • (2011) Int. J. Obes. (Lond.) , vol.35 , pp. 1511-1519
    • Erman, A.1    Veilleux, A.2    Tchernof, A.3
  • 35
    • 0032239547 scopus 로고    scopus 로고
    • Pathophysiology of the neororegulation of growth hormone secretion in experimental animals and the human
    • Giustina, A. & Veldhuis, J. D. Pathophysiology of the neororegulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19, 717-797 (1998).
    • (1998) Endocr. Rev. , vol.19 , pp. 717-797
    • Giustina, A.1    Veldhuis, J.D.2
  • 36
    • 0025787687 scopus 로고
    • Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men
    • Iranmanesh, A., Lizarralde, G. & Veldhuis, J. D. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. Clin. Endocrinol. Metab. 73, 1081-1088 (1991).
    • (1991) J. Clin. Endocrinol. Metab. , vol.73 , pp. 1081-1088
    • Iranmanesh, A.1    Lizarralde, G.2    Veldhuis, J.D.3
  • 37
    • 0025973802 scopus 로고
    • Dual effects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man
    • Veldhuis, J. D. et al. Dual effects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J. Clin. Endocrinol. Metab. 72, 51-59 (1991).
    • (1991) J. Clin. Endocrinol. Metab. , vol.72 , pp. 51-59
    • Veldhuis, J.D.1
  • 38
    • 0021746013 scopus 로고
    • Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction
    • Williams, T. et al. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N. Engl. J. Med. 311, 1403-1407 (1984).
    • (1984) N. Engl. J. Med. , vol.311 , pp. 1403-1407
    • Williams, T.1
  • 39
    • 0029886765 scopus 로고    scopus 로고
    • Abdominal adiposity and physical fittness are major determinants of age associated decline in stimulated GH secretion in healthy adults
    • Vahl, N., Jørgensen, J. O., Jurik, A. G. & Christiansen, J. S. Abdominal adiposity and physical fittness are major determinants of age associated decline in stimulated GH secretion in healthy adults. J. Clin. Endocrinol. Metab. 81, 2209-2215 (1996).
    • (1996) J. Clin. Endocrinol. Metab. , vol.81 , pp. 2209-2215
    • Vahl, N.1    Jørgensen, J.O.2    Jurik, A.G.3    Christiansen, J.S.4
  • 40
    • 70349916249 scopus 로고    scopus 로고
    • Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity
    • Bredella, M. A. et al. Peak growth hormone-releasing hormone-arginine- stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. J. Clin. Endocrinol. Metab. 94, 3995-4002 (2009).
    • (2009) J. Clin. Endocrinol. Metab. , vol.94 , pp. 3995-4002
    • Bredella, M.A.1
  • 41
    • 33747678664 scopus 로고    scopus 로고
    • Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity
    • Franco, C. et al. Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity. Eur. J. Endocrinol. 155, 261-268 (2006).
    • (2006) Eur. J. Endocrinol. , vol.155 , pp. 261-268
    • Franco, C.1
  • 42
    • 0032844435 scopus 로고    scopus 로고
    • Growth hormone (GH) status is an independent determinant of serum levels of cholesterol and triglycerides in healthy adults
    • Vahl, N., Klausen, I., Christiansen, J. S. & Jorgensen, J. O. Growth hormone (GH) status is an independent determinant of serum levels of cholesterol and triglycerides in healthy adults. Clin. Endocrinol. (Oxf.) 51, 309-316 (1999).
    • (1999) Clin. Endocrinol. (Oxf.) , vol.51 , pp. 309-316
    • Vahl, N.1    Klausen, I.2    Christiansen, J.S.3    Jorgensen, J.O.4
  • 43
    • 18144452003 scopus 로고    scopus 로고
    • Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults
    • Weltman, A. et al. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults. Metabolism 52, 73-80 (2003).
    • (2003) Metabolism , vol.52 , pp. 73-80
    • Weltman, A.1
  • 44
    • 14044276421 scopus 로고    scopus 로고
    • Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk
    • Miller, K. K. et al. Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J. Clin. Endocrinol. Metab. 90, 768-774 (2005).
    • (2005) J. Clin. Endocrinol. Metab. , vol.90 , pp. 768-774
    • Miller, K.K.1
  • 45
    • 47549103137 scopus 로고    scopus 로고
    • Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women
    • Utz, A. L., Yamamoto, A., Hemphill, L. & Miller, K. K. Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women. J. Clin. Endocrinol. Metab. 93, 2507-2514 (2008).
    • (2008) J. Clin. Endocrinol. Metab. , vol.93 , pp. 2507-2514
    • Utz, A.L.1    Yamamoto, A.2    Hemphill, L.3    Miller, K.K.4
  • 46
    • 57349141683 scopus 로고    scopus 로고
    • The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men
    • Makimura, H., Stanley, T., Mun, D., You, S. M. & Grinspoon, S. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J. Clin. Endocrinol. Metab. 93, 4254-4260 (2008).
    • (2008) J. Clin. Endocrinol. Metab. , vol.93 , pp. 4254-4260
    • Makimura, H.1    Stanley, T.2    Mun, D.3    You, S.M.4    Grinspoon, S.5
  • 47
    • 0037369597 scopus 로고    scopus 로고
    • Blunted lipolytic response to fasting in abdominally obese women: Evidence for involvement of hyposomatotropism
    • Buijs, M. M. et al. Blunted lipolytic response to fasting in abdominally obese women: evidence for involvement of hyposomatotropism. Am. J. Clin. Nutr. 77, 544-550 (2003).
    • (2003) Am. J. Clin. Nutr. , vol.77 , pp. 544-550
    • Buijs, M.M.1
  • 48
    • 0035049818 scopus 로고    scopus 로고
    • Organization and evolution of the human growth hormone receptor gene 5'-flanking region
    • Goodyer, C. G. et al. Organization and evolution of the human growth hormone receptor gene 5'-flanking region. Endocrinology 142, 1923-1934 (2001).
    • (2001) Endocrinology , vol.142 , pp. 1923-1934
    • Goodyer, C.G.1
  • 49
    • 0346628520 scopus 로고
    • Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism
    • Godowski, P. J. et al. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc. Natl Acad. Sci. USA 86, 8083-8087 (1989).
    • (1989) Proc. Natl Acad. Sci. USA , vol.86 , pp. 8083-8087
    • Godowski, P.J.1
  • 50
    • 3042780191 scopus 로고    scopus 로고
    • A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone
    • Dos Santos, C. et al. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat. Genet. 36, 720-724 (2004).
    • (2004) Nat. Genet. , vol.36 , pp. 720-724
    • Dos Santos, C.1
  • 51
    • 34548279858 scopus 로고    scopus 로고
    • GHR exon 3 polymorphism: Association with type 2 diabetes mellitus and metabolic disorder
    • Strawbridge, R. J. et al. GHR exon 3 polymorphism: association with type 2 diabetes mellitus and metabolic disorder. Growth Horm. IGF Res. 17, 392-398 (2007).
    • (2007) Growth Horm. IGF Res. , vol.17 , pp. 392-398
    • Strawbridge, R.J.1
  • 52
    • 79957497637 scopus 로고    scopus 로고
    • The growth hormone receptor (GHR) exon 3 polymorphism and its correlation with metabolic profiles in obese Chinese children
    • Gao, L. et al. The growth hormone receptor (GHR) exon 3 polymorphism and its correlation with metabolic profiles in obese Chinese children. Pediatr. Diabetes 12, 429-434 (2011).
    • (2011) Pediatr. Diabetes , vol.12 , pp. 429-434
    • Gao, L.1
  • 53
    • 0015107186 scopus 로고
    • Effects of triiodothyronine, growth hormone and anabolic steroids on nitrogen excretion and oxygen consumption of obese patients
    • Bray, G. A., Raben, M. S., Londono, J. & Gallagher, T. F. Jr. Effects of triiodothyronine, growth hormone and anabolic steroids on nitrogen excretion and oxygen consumption of obese patients. J. Clin. Endocrinol. Metab. 33, 293-300 (1971).
    • (1971) J. Clin. Endocrinol. Metab. , vol.33 , pp. 293-300
    • Bray, G.A.1    Raben, M.S.2    Londono, J.3    Gallagher Jr., T.F.4
  • 54
    • 0023251828 scopus 로고
    • Growth hormone administration conserves lean body mass during dietary restriction in obese subjects
    • Clemmons, D. R., Snyder, D. K., Williams, R. & Underwood, L. E. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects. J. Clin. Endocrinol. Metab. 64, 878-883 (1987).
    • (1987) J. Clin. Endocrinol. Metab. , vol.64 , pp. 878-883
    • Clemmons, D.R.1    Snyder, D.K.2    Williams, R.3    Underwood, L.E.4
  • 55
    • 0023721904 scopus 로고
    • Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: Effects on anabolism, lipolysis and body composition
    • Snyder, D. K., Clemmons, D. R. & Underwood, L. E. Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis and body composition. J. Clin. Endocrinol. Metab. 67, 54-61 (1988).
    • (1988) J. Clin. Endocrinol. Metab. , vol.67 , pp. 54-61
    • Snyder, D.K.1    Clemmons, D.R.2    Underwood, L.E.3
  • 56
    • 0025146127 scopus 로고
    • Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent
    • Snyder, D. K., Underwood, L. E. & Clemmons, D. R. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent. Am. J. Clin. Nutr. 52, 431-437 (1990).
    • (1990) Am. J. Clin. Nutr. , vol.52 , pp. 431-437
    • Snyder, D.K.1    Underwood, L.E.2    Clemmons, D.R.3
  • 57
    • 0033052163 scopus 로고    scopus 로고
    • Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults
    • Kim, K. R. et al. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults. Horm. Res. 51, 78-84 (1999).
    • (1999) Horm. Res. , vol.51 , pp. 78-84
    • Kim, K.R.1
  • 58
    • 0031825711 scopus 로고    scopus 로고
    • Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women
    • Tagliaferri, M. et al. Metabolic effects of biosynthetic growth hormone treatment in severely energy-restricted obese women. Int. J. Obes. Relat. Metab. Disord. 22, 836-841 (1998).
    • (1998) Int. J. Obes. Relat. Metab. Disord. , vol.22 , pp. 836-841
    • Tagliaferri, M.1
  • 59
    • 0027429860 scopus 로고
    • Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency
    • Fowelin, J., Attvall, S., Lager, I. & Bengtsson, B. A. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 42, 1443-1447 (1993).
    • (1993) Metabolism , vol.42 , pp. 1443-1447
    • Fowelin, J.1    Attvall, S.2    Lager, I.3    Bengtsson, B.A.4
  • 60
    • 0028233730 scopus 로고
    • Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: A double-blind placebo-controlled study
    • Jørgensen, J. O. et al. Fuel metabolism, energy expenditure, and thyroid function in growth hormone-treated obese women: a double-blind placebo-controlled study. Metabolism 43, 872-877 (1994).
    • (1994) Metabolism , vol.43 , pp. 872-877
    • Jørgensen, J.O.1
  • 61
    • 0031970581 scopus 로고    scopus 로고
    • Effects of growth hormone treatment on the leptin system: Interactions with body composition and energy expenditure
    • Karlsson, C. et al. Effects of growth hormone treatment on the leptin system: interactions with body composition and energy expenditure. Eur. J. Endocrinol. 138, 408-414 (1998).
    • (1998) Eur. J. Endocrinol. , vol.138 , pp. 408-414
    • Karlsson, C.1
  • 62
    • 0024358129 scopus 로고
    • Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomittant thyroxine-substituted central hypothyroidism
    • Jørgensen, J. O. et al. Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomittant thyroxine-substituted central hypothyroidism. J. Clin. Endocrinol. Metab. 69, 1127-1132 (1989).
    • (1989) J. Clin. Endocrinol. Metab. , vol.69 , pp. 1127-1132
    • Jørgensen, J.O.1
  • 63
    • 0021678265 scopus 로고
    • Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden
    • Lapidus, L. et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br. Med. J. (Clin. Res. Ed.) 289, 1257-1261 (1984).
    • (1984) Br. Med. J. (Clin. Res. Ed.) , vol.289 , pp. 1257-1261
    • Lapidus, L.1
  • 64
    • 0021152686 scopus 로고
    • Abdominal tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913
    • Larsson, B. et al. Abdominal tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow-up of participants in the study of men born in 1913. Br. Med. J. (Clin. Res. Ed.) 288, 1401-1404 (1984).
    • (1984) Br. Med. J. (Clin. Res. Ed.) , vol.288 , pp. 1401-1404
    • Larsson, B.1
  • 65
    • 0031057076 scopus 로고    scopus 로고
    • Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure
    • Johannsson, G. et al. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J. Clin. Endocrinol. Metab. 82, 727-734 (1997).
    • (1997) J. Clin. Endocrinol. Metab. , vol.82 , pp. 727-734
    • Johannsson, G.1
  • 66
    • 15944394754 scopus 로고    scopus 로고
    • Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: A 12-month placebo-controlled trial
    • Franco, C. et al. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J. Clin. Endocrinol. Metab. 90, 1466-1474 (2005).
    • (2005) J. Clin. Endocrinol. Metab. , vol.90 , pp. 1466-1474
    • Franco, C.1
  • 67
    • 34447126377 scopus 로고    scopus 로고
    • Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: A 12-month, randomized, placebo-controlled trial
    • Franco, C. et al. Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: a 12-month, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 92, 2644-2647 (2007).
    • (2007) J. Clin. Endocrinol. Metab. , vol.92 , pp. 2644-2647
    • Franco, C.1
  • 68
    • 48749093932 scopus 로고    scopus 로고
    • Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: A randomized controlled trial
    • Lo, J. et al. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial. JAMA 300, 509-519 (2008).
    • (2008) JAMA , vol.300 , pp. 509-519
    • Lo, J.1
  • 69
    • 0038813735 scopus 로고    scopus 로고
    • Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly
    • Clemmons, D. R. Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary 5, 181-183 (2002).
    • (2002) Pituitary , vol.5 , pp. 181-183
    • Clemmons, D.R.1
  • 70
    • 11144256210 scopus 로고    scopus 로고
    • Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion
    • Jessen, N. et al. Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion. Am. J. Physiol. Endocrinol. Metab. 288, E194-E199 (2005).
    • (2005) Am. J. Physiol. Endocrinol. Metab. , vol.288
    • Jessen, N.1
  • 71
    • 47549084450 scopus 로고    scopus 로고
    • Growth hormone signaling in vivo in human muscle and adipose tissue: Impact of insulin, substrate background, and growth hormone receptor bckade
    • Nielsen, C. et al. Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor bckade. J. Clin. Endocrinol. Metab. 93, 2842-2850 (2008).
    • (2008) J. Clin. Endocrinol. Metab. , vol.93 , pp. 2842-2850
    • Nielsen, C.1
  • 72
    • 1542466784 scopus 로고    scopus 로고
    • Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice
    • Yakar, S. et al. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J. Clin. Invest. 113, 96-105 (2004).
    • (2004) J. Clin. Invest. , vol.113 , pp. 96-105
    • Yakar, S.1
  • 73
    • 27844460627 scopus 로고    scopus 로고
    • Increased P85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess
    • Barbour, L. A. et al. Increased P85α is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J. Biol. Chem. 280, 37489-37494 (2005).
    • (2005) J. Biol. Chem. , vol.280 , pp. 37489-37494
    • Barbour, L.A.1
  • 74
    • 34249656368 scopus 로고    scopus 로고
    • Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue: Mechanism for growth hormone-mediated insulin resistance
    • del Rincon, J. P. et al. Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes 56, 1638-1646 (2007).
    • (2007) Diabetes , vol.56 , pp. 1638-1646
    • Del Rincon, J.P.1
  • 75
    • 0038526307 scopus 로고    scopus 로고
    • Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle
    • Bramnert M. et al. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. J. Clin. Endocrinol. Metab. 88, 1455-1463 (2003).
    • (2003) J. Clin. Endocrinol. Metab. , vol.88 , pp. 1455-1463
    • Bramnert, M.1
  • 76
    • 0034901778 scopus 로고    scopus 로고
    • Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients
    • Nam, S. Y. et al. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord. 25, 1101-1107 (2001).
    • (2001) Int. J. Obes. Relat. Metab. Disord. , vol.25 , pp. 1101-1107
    • Nam, S.Y.1
  • 77
    • 33644929020 scopus 로고    scopus 로고
    • Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control
    • Ahn, C. W. et al. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control. Clin. Endocrinol. (Oxf.) 64, 444-449 (2006).
    • (2006) Clin. Endocrinol. (Oxf.) , vol.64 , pp. 444-449
    • Ahn, C.W.1
  • 78
    • 49749091133 scopus 로고    scopus 로고
    • Growth hormone and changes in energy balance in growth hormone deficient adults
    • Deepak, D. et al. Growth hormone and changes in energy balance in growth hormone deficient adults. Eur. J. Clin. Invest. 38, 622-627 (2008).
    • (2008) Eur. J. Clin. Invest. , vol.38 , pp. 622-627
    • Deepak, D.1
  • 79
    • 17944381371 scopus 로고    scopus 로고
    • Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency
    • Hernberg-Ståhl, E. et al. Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. J. Clin. Endocrinol. Metab. 86, 5277-5281 (2001).
    • (2001) J. Clin. Endocrinol. Metab. , vol.86 , pp. 5277-5281
    • Hernberg-Ståhl, E.1
  • 80
    • 0029057483 scopus 로고
    • Energy and macronutrient intake in growth hormone-deficient adults: The effect of growth hormone replacement
    • Snel, Y. E., Brummer, R. J., Doerga, M. E., Zelissen, P. M. & Koppeschaar, H. P. Energy and macronutrient intake in growth hormone-deficient adults: the effect of growth hormone replacement. Eur. J. Clin. Nutr. 49, 492-500 (1995).
    • (1995) Eur. J. Clin. Nutr. , vol.49 , pp. 492-500
    • Snel, Y.E.1    Brummer, R.J.2    Doerga, M.E.3    Zelissen, P.M.4    Koppeschaar, H.P.5
  • 81
    • 0028890279 scopus 로고
    • Persistent lipolytic effect of exogenous growth hormone during caloric restriction
    • Snyder, D. K., Underwood, L. E. & Clemmons, D. R. Persistent lipolytic effect of exogenous growth hormone during caloric restriction. Am. J. Med. 98, 129-134 (1995).
    • (1995) Am. J. Med. , vol.98 , pp. 129-134
    • Snyder, D.K.1    Underwood, L.E.2    Clemmons, D.R.3
  • 82
    • 1442352241 scopus 로고    scopus 로고
    • Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity
    • Albert, S. G. & Mooradian, A. D. Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity. J. Clin. Endocrinol. Metab. 89, 695-701 (2004).
    • (2004) J. Clin. Endocrinol. Metab. , vol.89 , pp. 695-701
    • Albert, S.G.1    Mooradian, A.D.2
  • 83
    • 0034235093 scopus 로고    scopus 로고
    • Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients
    • Richelsen, B. et al. Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism 49, 906-911 (2000).
    • (2000) Metabolism , vol.49 , pp. 906-911
    • Richelsen, B.1
  • 84
    • 84870753316 scopus 로고    scopus 로고
    • Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: A randomized controlled trial
    • Makimura, H. et al. Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial. J. Clin. Endocrinol. Metab. 97, 4769-4779 (2012).
    • (2012) J. Clin. Endocrinol. Metab. , vol.97 , pp. 4769-4779
    • Makimura, H.1
  • 85
    • 34249801228 scopus 로고    scopus 로고
    • Effects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: A factorial clinical trial
    • Attallah, H., Friedlander, A. L., Nino-Murcia, M. & Hoffman, A. R. Effects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: a factorial clinical trial. PLoS Clin. Trials 2, e21 (2007).
    • (2007) PLoS Clin. Trials , vol.2
    • Attallah, H.1    Friedlander, A.L.2    Nino-Murcia, M.3    Hoffman, A.R.4
  • 86
    • 0033304520 scopus 로고    scopus 로고
    • Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins but not lipoprotein(a)
    • Svensson, J. et al. Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins but not lipoprotein(a). J. Clin. Endocrinol. Metab. 84, 2028-2033 (1999).
    • (1999) J. Clin. Endocrinol. Metab. , vol.84 , pp. 2028-2033
    • Svensson, J.1
  • 87
    • 84859415664 scopus 로고    scopus 로고
    • Effects of GH in women with abdominal adiposity: A 6-month randomized, double-blind, placebo-controlled trial
    • Bredella, M. A. et al. Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial. Eur. J. Endocrinol. 166, 601-611 (2012).
    • (2012) Eur. J. Endocrinol. , vol.166 , pp. 601-611
    • Bredella, M.A.1
  • 88
    • 58149387611 scopus 로고    scopus 로고
    • Effects of recombinant human growth hormone therapy in obesity in adults: A meta analysis
    • Mekala, K. C. & Tritos, N. A. Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis. J. Clin. Endocrinol. Metab. 94, 130-137 (2009).
    • (2009) J. Clin. Endocrinol. Metab. , vol.94 , pp. 130-137
    • Mekala, K.C.1    Tritos, N.A.2
  • 89
    • 1442290249 scopus 로고    scopus 로고
    • Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome
    • Herrmann, B. L. et al. Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome. Horm. Metab. Res. 36, 54-61 (2004).
    • (2004) Horm. Metab. Res. , vol.36 , pp. 54-61
    • Herrmann, B.L.1
  • 90
    • 79961242170 scopus 로고    scopus 로고
    • Growth hormone (GH)-induced insulin resistance is rapidly reversible: An experimental study in GH-deficient adults
    • Krusenstjerna-Hafstrøm, T. et al. Growth hormone (GH)-induced insulin resistance is rapidly reversible: an experimental study in GH-deficient adults. J. Clin. Endocrinol. Metab. 96, 2548-2557 (2011).
    • (2011) J. Clin. Endocrinol. Metab. , vol.96 , pp. 2548-2557
    • Krusenstjerna-Hafstrøm, T.1
  • 91
    • 15644364105 scopus 로고    scopus 로고
    • Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure
    • Svensson, J. et al. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J. Clin. Endocrinol. Metab. 83, 362-369 (1998).
    • (1998) J. Clin. Endocrinol. Metab. , vol.83 , pp. 362-369
    • Svensson, J.1
  • 92
    • 36849058739 scopus 로고    scopus 로고
    • Metabolic effects of a growth hormone-releasing factor in patients with HIV
    • Falutz, J. et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N. Engl. J. Med. 357, 2359-2370 (2007).
    • (2007) N. Engl. J. Med. , vol.357 , pp. 2359-2370
    • Falutz, J.1
  • 93
    • 62749144043 scopus 로고    scopus 로고
    • Age-related changes in body composition of bovine growth hormone transgenic mice
    • Palmer, A. J. et al. Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 150, 1353-1360 (2009).
    • (2009) Endocrinology , vol.150 , pp. 1353-1360
    • Palmer, A.J.1
  • 94
    • 80855128727 scopus 로고    scopus 로고
    • Plasma proteomic profiles of bovine growth hormone transgenic mice as they age
    • Ding, J., Berryman, D. E. & Kopchick, J. J. Plasma proteomic profiles of bovine growth hormone transgenic mice as they age. Transgenic Res. 20, 1305-1320 (2011).
    • (2011) Transgenic Res. , vol.20 , pp. 1305-1320
    • Ding, J.1    Berryman, D.E.2    Kopchick, J.J.3
  • 95
    • 0023688545 scopus 로고
    • Expression of insulin-like growth factor i in transgenic mice with elevated levels of growth hormone is correlated with growth
    • Mathews, L. S., Hammer, R. E., Brinster, R. L. & Palmiter, R. D. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 123, 433-437 (1988).
    • (1988) Endocrinology , vol.123 , pp. 433-437
    • Mathews, L.S.1    Hammer, R.E.2    Brinster, R.L.3    Palmiter, R.D.4
  • 97
    • 33646767090 scopus 로고    scopus 로고
    • Effect of growth hormone on susceptibility to diet-induced obesity
    • Berryman, D. E. et al. Effect of growth hormone on susceptibility to diet-induced obesity. Endocrinology 147, 2801-2808 (2006).
    • (2006) Endocrinology , vol.147 , pp. 2801-2808
    • Berryman, D.E.1
  • 99
    • 3042815659 scopus 로고    scopus 로고
    • Comparing adiposity profiles in three mouse models with altered GH signaling
    • Berryman, D. E. et al. Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Horm. IGF Res. 14, 309-318 (2004).
    • (2004) Growth Horm. IGF Res. , vol.14 , pp. 309-318
    • Berryman, D.E.1
  • 100
    • 19944426672 scopus 로고    scopus 로고
    • Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia
    • Bohlooly, Y. M. et al. Growth hormone overexpression in the central nervous system results in hyperphagia-induced obesity associated with insulin resistance and dyslipidemia. Diabetes 54, 51-62 (2005).
    • (2005) Diabetes , vol.54 , pp. 51-62
    • Bohlooly, Y.M.1
  • 101
    • 34250884797 scopus 로고    scopus 로고
    • Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice
    • Wang, Z., Masternak, M. M., Al-Regaiey, K. A. & Bartke, A. Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 148, 2845-2853 (2007).
    • (2007) Endocrinology , vol.148 , pp. 2845-2853
    • Wang, Z.1    Masternak, M.M.2    Al-Regaiey, K.A.3    Bartke, A.4
  • 102
    • 12344326642 scopus 로고    scopus 로고
    • Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet
    • Olsson, B. et al. Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. Endocrinology 146, 920-930 (2005).
    • (2005) Endocrinology , vol.146 , pp. 920-930
    • Olsson, B.1
  • 103
    • 0242490056 scopus 로고    scopus 로고
    • Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice
    • Bartke, A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 78, 210-216 (2003).
    • (2003) Neuroendocrinology , vol.78 , pp. 210-216
    • Bartke, A.1
  • 104
    • 82355165082 scopus 로고    scopus 로고
    • Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner
    • Gahete, M. D. et al. Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner. Endocrinology 152, 4825-4837 (2011).
    • (2011) Endocrinology , vol.152 , pp. 4825-4837
    • Gahete, M.D.1
  • 105
    • 79958243025 scopus 로고    scopus 로고
    • Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse
    • List, E. O. et al. Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHR-/-) mouse. Endocr. Rev. 32, 356-386 (2011).
    • (2011) Endocr. Rev. , vol.32 , pp. 356-386
    • List, E.O.1
  • 106
    • 12644257576 scopus 로고    scopus 로고
    • A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse)
    • Zhou, Y. et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc. Natl Acad. Sci. USA 94, 13215-13220 (1997).
    • (1997) Proc. Natl Acad. Sci. USA , vol.94 , pp. 13215-13220
    • Zhou, Y.1
  • 107
    • 43449083772 scopus 로고    scopus 로고
    • Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: Novel findings
    • Bartke, A. Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: novel findings. Aging Cell 7, 285-290 (2008).
    • (2008) Aging Cell , vol.7 , pp. 285-290
    • Bartke, A.1
  • 108
    • 0041419437 scopus 로고    scopus 로고
    • Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor i levels and increased life span
    • Coschigano, K. T. et al. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144, 3799-3810 (2003).
    • (2003) Endocrinology , vol.144 , pp. 3799-3810
    • Coschigano, K.T.1
  • 109
    • 74049103564 scopus 로고    scopus 로고
    • Two-year body composition analyses of long-lived GHR null mice
    • Berryman, D. E. et al. Two-year body composition analyses of long-lived GHR null mice. J. Gerontol. A. Biol. Sci. Med. Sci. 65, 31-40 (2010).
    • (2010) J. Gerontol. A. Biol. Sci. Med. Sci. , vol.65 , pp. 31-40
    • Berryman, D.E.1
  • 110
    • 33644855561 scopus 로고    scopus 로고
    • Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice
    • Egecioglu, E. et al. Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. Am. J. Physiol. Endocrinol. Metab. 290, E317-E325 (2006).
    • (2006) Am. J. Physiol. Endocrinol. Metab. , vol.290
    • Egecioglu, E.1
  • 111
    • 33751044208 scopus 로고    scopus 로고
    • Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: Site-specific effects upon proliferation, differentiation and hormone sensitivity
    • Flint, D. J., Binart, N., Boumard, S., Kopchick, J. J. & Kelly, P. Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity. J. Endocrinol. 191, 101-111 (2006).
    • (2006) J. Endocrinol. , vol.191 , pp. 101-111
    • Flint, D.J.1    Binart, N.2    Boumard, S.3    Kopchick, J.J.4    Kelly, P.5
  • 112
    • 33745219182 scopus 로고    scopus 로고
    • Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics
    • Bonkowski, M. S. et al. Long-lived growth hormone receptor knockout mice show a delay in age-related changes of body composition and bone characteristics. J. Gerontol. A. Biol. Sci. Med. Sci. 61, 562-567 (2006).
    • (2006) J. Gerontol. A. Biol. Sci. Med. Sci. , vol.61 , pp. 562-567
    • Bonkowski, M.S.1
  • 113
    • 0037315784 scopus 로고    scopus 로고
    • Enlargement of interscapular brown adipose tissue in growth hormone antagonist transgenic and in growth hormone receptor gene-disrupted dwarf mice
    • Li, Y., Knapp, J. R. & Kopchick, J. J. Enlargement of interscapular brown adipose tissue in growth hormone antagonist transgenic and in growth hormone receptor gene-disrupted dwarf mice. Exp. Biol. Med. (Maywood) 228, 207-215 (2003).
    • (2003) Exp. Biol. Med. (Maywood) , vol.228 , pp. 207-215
    • Li, Y.1    Knapp, J.R.2    Kopchick, J.J.3
  • 114
    • 4143085927 scopus 로고    scopus 로고
    • Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice
    • Liu, J. L. et al. Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. Am. J. Physiol. Endocrinol. Metab. 287, E405-E413 (2004).
    • (2004) Am. J. Physiol. Endocrinol. Metab. , vol.287
    • Liu, J.L.1
  • 115
    • 84855832253 scopus 로고    scopus 로고
    • Metabolic effects of intra-abdominal fat in GHRKO mice
    • Masternak, M. M. et al. Metabolic effects of intra-abdominal fat in GHRKO mice. Aging Cell 11, 73-81 (2012).
    • (2012) Aging Cell , vol.11 , pp. 73-81
    • Masternak, M.M.1
  • 116
    • 84875067801 scopus 로고    scopus 로고
    • Adiponectin in mice with altered growth hormone action: Links to insulin sensitivity and longevity?
    • Lubbers, E. R. et al. Adiponectin in mice with altered growth hormone action: links to insulin sensitivity and longevity? J. Endocrinol. 216, 363-374 (2013).
    • (2013) J. Endocrinol , vol.216 , pp. 363-374
    • Lubbers, E.R.1
  • 117
    • 27744445115 scopus 로고    scopus 로고
    • Caloric restriction results in decreased expression of peroxisome proliferator-activated receptor superfamily in muscle of normal and long-lived growth hormone receptor/binding protein knockout mice
    • Masternak, M. M. et al. Caloric restriction results in decreased expression of peroxisome proliferator-activated receptor superfamily in muscle of normal and long-lived growth hormone receptor/binding protein knockout mice. J. Gerontol. A. Biol. Sci. Med. Sci. 60, 1238-1245 (2005).
    • (2005) J. Gerontol. A. Biol. Sci. Med. Sci. , vol.60 , pp. 1238-1245
    • Masternak, M.M.1
  • 118
    • 74649083738 scopus 로고    scopus 로고
    • Daily energy balance in growth hormone receptor/binding protein (GHR -/-) gene-disrupted mice is achieved through an increase in dark-phase energy efficiency
    • Longo, K. A. et al. Daily energy balance in growth hormone receptor/binding protein (GHR -/-) gene-disrupted mice is achieved through an increase in dark-phase energy efficiency. Growth Horm. IGF Res. 20, 73-79 (2010).
    • (2010) Growth Horm. IGF Res. , vol.20 , pp. 73-79
    • Longo, K.A.1
  • 119
    • 84874507612 scopus 로고    scopus 로고
    • The role of GH in adipose tissue: Lessons from adipose-specific GH receptor gene-disrupted mice
    • List, E. O. et al. The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. Mol. Endocrinol. 27, 524-535 (2013).
    • (2013) Mol. Endocrinol. , vol.27 , pp. 524-535
    • List, E.O.1
  • 121
    • 0029065480 scopus 로고
    • Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice
    • Surwit, R. S. et al. Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A/J mice. Metabolism 44, 645-651 (1995).
    • (1995) Metabolism , vol.44 , pp. 645-651
    • Surwit, R.S.1
  • 122
    • 84865408230 scopus 로고    scopus 로고
    • The decline in pulsatile GH secretion throughout early adulthood in mice is exacerbated by dietary-induced weight gain
    • Huang, L. et al. The decline in pulsatile GH secretion throughout early adulthood in mice is exacerbated by dietary-induced weight gain. Endocrinology 153, 4380-4388 (2012).
    • (2012) Endocrinology , vol.153 , pp. 4380-4388
    • Huang, L.1
  • 123
    • 67650649523 scopus 로고    scopus 로고
    • Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes
    • List, E. O. et al. Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes. Diabetologia 52, 1647-1655 (2009).
    • (2009) Diabetologia , vol.52 , pp. 1647-1655
    • List, E.O.1
  • 124
    • 0001651621 scopus 로고
    • Breeding of mouse strains for diabetes mellitus
    • Nishimura M. Breeding of mouse strains for diabetes mellitus. Exp. Anim. 18, 147-157 (1969).
    • (1969) Exp. Anim. , vol.18 , pp. 147-157
    • Nishimura, M.1
  • 125
    • 7644237617 scopus 로고    scopus 로고
    • Effects of growth hormone (GH) on mRNA levels of uncoupling proteins 1, 2, and 3 in brown and white adipose tissues and skeletal muscle in obese mice
    • Hioki, C. et al. Effects of growth hormone (GH) on mRNA levels of uncoupling proteins 1, 2, and 3 in brown and white adipose tissues and skeletal muscle in obese mice. Horm. Metab. Res. 36, 607-613 (2004).
    • (2004) Horm. Metab. Res. , vol.36 , pp. 607-613
    • Hioki, C.1
  • 126
    • 13044294029 scopus 로고    scopus 로고
    • Liver-derived insulin-like growth factor i (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
    • Sjögren, K. et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc. Natl Acad. Sci. USA 96, 7088-7092 (1999).
    • (1999) Proc. Natl Acad. Sci. USA , vol.96 , pp. 7088-7092
    • Sjögren, K.1
  • 127
    • 0023616485 scopus 로고
    • Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary
    • Casanueva, F. F. et al. Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary. J. Clin. Endocrinol. Metab. 65, 634-642 (1987).
    • (1987) J. Clin. Endocrinol. Metab. , vol.65 , pp. 634-642
    • Casanueva, F.F.1
  • 129
    • 0035491321 scopus 로고    scopus 로고
    • Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure
    • Nielsen, S., Møller, N., Christiansen, J. S. & Jørgensen, J. O. Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure. Diabetes 50, 2301-2308 (2001).
    • (2001) Diabetes , vol.50 , pp. 2301-2308
    • Nielsen, S.1    Møller, N.2    Christiansen, J.S.3    Jørgensen, J.O.4
  • 130
    • 78650850032 scopus 로고    scopus 로고
    • GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism
    • Barclay, J. L. et al. GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Endocrinology 152, 181-192 (2011).
    • (2011) Endocrinology , vol.152 , pp. 181-192
    • Barclay, J.L.1
  • 131
    • 84862727190 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy
    • Nishizawa, H. et al. Nonalcoholic fatty liver disease in adult hypopituitary patients with GH deficiency and the impact of GH replacement therapy. Eur. J. Endocrinol. 167, 67-74 (2012).
    • (2012) Eur. J. Endocrinol. , vol.167 , pp. 67-74
    • Nishizawa, H.1
  • 132
    • 0034489210 scopus 로고    scopus 로고
    • Insulin regulation of human hepatic growth hormone receptors: Divergent effects on biosynthesis and surface translocation
    • Leung, K. C., Doyle, N., Ballesteros, M., Waters, M. J. & Ho, K. K. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J. Clin. Endocrinol. Metab. 85, 4712-4720 (2000).
    • (2000) J. Clin. Endocrinol. Metab. , vol.85 , pp. 4712-4720
    • Leung, K.C.1    Doyle, N.2    Ballesteros, M.3    Waters, M.J.4    Ho, K.K.5
  • 133
    • 78651094465 scopus 로고    scopus 로고
    • Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat
    • Schulz, T. J. et al. Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc. Natl Acad. Sci. USA 108, 143-148 (2011).
    • (2011) Proc. Natl Acad. Sci. USA , vol.108 , pp. 143-148
    • Schulz, T.J.1
  • 134
    • 78049295202 scopus 로고    scopus 로고
    • Fibrosis in human adipose tissue: Composition, distribution, and link with lipid metabolism and fat mass loss
    • Divoux, A. et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 59, 2817-2825 (2010).
    • (2010) Diabetes , vol.59 , pp. 2817-2825
    • Divoux, A.1
  • 135
    • 34547186534 scopus 로고    scopus 로고
    • CIDE-A gene expression is decreased in white adipose tissue of growth hormone receptor/binding protein gene disrupted mice and with high-fat feeding of normal mice
    • Kelder, B. et al. CIDE-A gene expression is decreased in white adipose tissue of growth hormone receptor/binding protein gene disrupted mice and with high-fat feeding of normal mice. Growth Horm. IGF Res. 17, 346-351 (2007).
    • (2007) Growth Horm. IGF Res. , vol.17 , pp. 346-351
    • Kelder, B.1
  • 136
    • 0025766522 scopus 로고
    • Exogenous human growth hormone reduces body fat in obese women
    • Skaggs, S. R. & Crist, D. M. Exogenous human growth hormone reduces body fat in obese women. Horm. Res. 35, 19-24 (1991).
    • (1991) Horm. Res. , vol.35 , pp. 19-24
    • Skaggs, S.R.1    Crist, D.M.2
  • 137
    • 0029020117 scopus 로고
    • Growth hormone administration in addition to a very low calorie diet and an exercise program in obese subjects
    • Drent, M. L., Wever, L. D., Ader, H. J. & van der Veen, E. A. Growth hormone administration in addition to a very low calorie diet and an exercise program in obese subjects. Eur. J. Endocrinol. 132, 565-572 (1995).
    • (1995) Eur. J. Endocrinol. , vol.132 , pp. 565-572
    • Drent, M.L.1    Wever, L.D.2    Ader, H.J.3    Van Der Veen, E.A.4
  • 138
    • 79251638798 scopus 로고    scopus 로고
    • Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes
    • Luque, R. M. et al. Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes. PLoS ONE 6, e15767 (2011).
    • (2011) PLoS ONE , vol.6
    • Luque, R.M.1
  • 139
    • 0026377007 scopus 로고
    • Glycine 119 of bovine growth hormone is critical for growth-promoting activity
    • Chen, W. Y., Wight, D. C., Mehta, B. V., Wagner, T. E. & Kopchick, J. J. Glycine 119 of bovine growth hormone is critical for growth-promoting activity. Mol. Endocrinol. 5, 1845-1852 (1991).
    • (1991) Mol. Endocrinol. , vol.5 , pp. 1845-1852
    • Chen, W.Y.1    Wight, D.C.2    Mehta, B.V.3    Wagner, T.E.4    Kopchick, J.J.5
  • 140
    • 0029608970 scopus 로고
    • The Ames dwarf gene is required for Pit-1 gene activation
    • Andersen, B. et al. The Ames dwarf gene is required for Pit-1 gene activation. Dev. Biol. 172, 495-503 (1995).
    • (1995) Dev. Biol. , vol.172 , pp. 495-503
    • Andersen, B.1
  • 142
    • 0037322925 scopus 로고    scopus 로고
    • Body composition of prolactin-, growth hormone, and thyrotropin-deficient Ames dwarf mice
    • Heiman, M. L., Tinsley, F. C., Mattison, J. A., Hauck, S. & Bartke, A. Body composition of prolactin-, growth hormone, and thyrotropin-deficient Ames dwarf mice. Endocrine 20, 149-154 (2003).
    • (2003) Endocrine , vol.20 , pp. 149-154
    • Heiman, M.L.1    Tinsley, F.C.2    Mattison, J.A.3    Hauck, S.4    Bartke, A.5
  • 143
    • 0025014024 scopus 로고
    • Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1
    • Li, S. et al. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347, 528-533 (1990).
    • (1990) Nature , vol.347 , pp. 528-533
    • Li, S.1
  • 144
    • 0035811073 scopus 로고    scopus 로고
    • Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production
    • Flurkey, K., Papaconstantinou, J., Miller, R. A. & Harrison, D. E. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl Acad. Sci. USA 98, 6736-6741 (2001).
    • (2001) Proc. Natl Acad. Sci. USA , vol.98 , pp. 6736-6741
    • Flurkey, K.1    Papaconstantinou, J.2    Miller, R.A.3    Harrison, D.E.4
  • 145
    • 0027455584 scopus 로고
    • Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4
    • Donahue, L. R. & Beamer, W. G. Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. J. Endocrinol. 136, 91-104 (1993).
    • (1993) J. Endocrinol. , vol.136 , pp. 91-104
    • Donahue, L.R.1    Beamer, W.G.2
  • 146
    • 0347664057 scopus 로고    scopus 로고
    • IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice
    • Holzenberger, M. et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421, 182-187 (2003).
    • (2003) Nature , vol.421 , pp. 182-187
    • Holzenberger, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.